Search

Your search keyword '"Pella Daniel"' showing total 457 results

Search Constraints

Start Over You searched for: Author "Pella Daniel" Remove constraint Author: "Pella Daniel"
457 results on '"Pella Daniel"'

Search Results

1. PCSK9 concentrations in different stages of subclinical atherosclerosis and their relationship with inflammation

2. Prevalence of statin intolerance: a meta-analysis

3. Step-by-step diagnosis and management of the nocebo/drucebo effect in statin-associated muscle symptoms patients: a position paper from the International Lipid Expert Panel (ILEP).

4. Kidney and Cardiovascular Effects of Canagliflozin According to Age and Sex: A Post Hoc Analysis of the CREDENCE Randomized Clinical Trial

5. Nutraceutical approaches to non-alcoholic fatty liver disease (NAFLD): A position paper from the International Lipid Expert Panel (ILEP)

7. Western diets and risk of non-communicable diseases

9. PRE-HEART FAILURE IN THE LIGHT OF 2D AND 3D SPECKLE TRACKING ECHOCARDIOGRAPHY: A COMPREHENSIVE REVIEW

10. Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol

11. Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab

12. 2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk

13. Retention projection enables accurate calculation of liquid chromatographic retention times across labs and methods

14. Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

16. The Role of Nutraceuticals in Statin Intolerant Patients

17. Relationship of C-reactive protein reduction to cardiovascular event reduction following treatment with canakinumab: a secondary analysis from the CANTOS randomised controlled trial

18. Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial

19. Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial

20. Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial

21. Chapter 1 - History of medicine from ancient times to present

23. Regional differences in physicians’ behavior and factors influencing the intensity of PCSK9 inhibitor therapy with alirocumab: a subanalysis of the ODYSSEY APPRISE study

25. Evolutionary Diet and Evolution of Man

28. List of Contributors

30. Globalization of Diets and Risk of Noncommunicable Diseases

32. Nutraceutical approaches to non-alcoholic fatty liver disease (NAFLD): A position paper from the International Lipid Expert Panel (ILEP)

42. High Exogenous Antioxidant, Restorative Treatment for Prevention of Heart Failure: The Heart Diet

44. CoQ10 in the Treatment of Heart and Vascular Disease

45. Nutrition and the Brain-Heart Connection

47. Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

48. Lipid-lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel

Catalog

Books, media, physical & digital resources